Sherry Tong, Jordan C Scott, Enwono Eyoh, Derek W Werthmann, Addison E Stone, Amelie E Murrell, Gilberto Sabino-Santos, Ivy V Trinh, Sruti Chandra, Debra H Elliott, Ashley R Smira, Jalene V Velazquez, John Schieffelin, Bo Ning, Tony Hu, Jay K Kolls, Samuel J Landry, Kevin J Zwezdaryk, James E Robinson, Bronwyn M Gunn, Felicia A Rabito, Elizabeth B Norton
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes a spectrum of clinical outcomes that may be complicated by severe asthma. Antiviral immunity is often compromised in patients with asthma; however, whether this is true for SARS-CoV-2 immunity and children is unknown. OBJECTIVE: We aimed to evaluate SARS-CoV-2 immunity in children with asthma on the basis of infection or vaccination history and compared to respiratory syncytial viral or allergen (eg, cockroach, dust mite)-specific immunity...
May 2024: J Allergy Clin Immunol Glob